Schedule 13G ownership disclosure
Jade Biosciences Inc
Common Stock, $0.0001 par value per share · CUSIP: 008064206
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 1,340,703.00 · Class: 4.2%
- FHMLSP, L.P.
Shares: 1,340,703.00 · Class: 4.2%
- FHMLSP, L.L.C.
Shares: 1,340,703.00 · Class: 4.2%
- Frazier Life Sciences Public Overage Fund, L.P.
Shares: 395,508.00 · Class: 1.2%
- FHMLSP Overage, L.P.
Shares: 395,508.00 · Class: 1.2%
- FHMLSP Overage, L.L.C.
Shares: 395,508.00 · Class: 1.2%
- Frazier Life Sciences X, L.P.
Shares: 11,897.00 · Class: 0.0%
- FHMLS X, L.P.
Shares: 11,897.00 · Class: 0.0%
- FHMLS X, L.L.C.
Shares: 11,897.00 · Class: 0.0%
- Frazier Life Sciences XI, L.P.
Shares: 24,008.00 · Class: 0.1%
- FHMLS XI, L.P.
Shares: 24,008.00 · Class: 0.1%
- FHMLS XI, L.L.C.
Shares: 24,008.00 · Class: 0.1%
- James N. Topper
Shares: 11,897.00 · Class: 0.0%
- Patrick J. Heron
Shares: 11,897.00 · Class: 0.0%
- Albert Cha
Shares: 0.00 · Class: 0.0%
- James Brush
Shares: 0.00 · Class: 0.0%
- Daniel Estes
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021799
- Form type
- SCHEDULE 13G/A
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership